🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsDanuglipron dose optimization — September 2026 Page 2

Danuglipron dose optimization — September 2026

rachel_ABQ Wed, Jan 24, 2024 at 1:53 AM 9 replies 2,182 viewsPage 2 of 2
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Jan 24, 2024 at 10:55 AM#6
Dr.ReproEndo said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

Last edited: Jan 24, 2024 at 2:55 PM
45 15maya_sedona, stefan_berlin, Dr.EM_Chicago and 42 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jan 24, 2024 at 2:29 PM#7

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Jan 24, 2024 at 8:29 PM
44 14InsuranceTom, WendyG_ATL, SaraMom3 and 41 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Jan 24, 2024 at 6:03 PM#8
mike_nyc said:
I do not accept that the fasting window is a minor inconvenience.

Adding the part of the answer the thread has not reached. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

43 13MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 40 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Jan 24, 2024 at 9:37 PM#9

Following on from TomFromTexas — and this may be the naive question:

Whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong?

42 12TrialTracker_MD, JennaRN, LabKate and 39 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Jan 25, 2024 at 2:43 PM#10

OP back with an update, since a thread like this is useless without one.

Follow-up: moving the tablet to the moment I wake, before anything else, was the whole fix. The dose never changed.

22 22Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 19 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register